Transgenic mice harboring both HBx and pre-S2 mutant display consistently activated mTOR signal throughout the liver tumorigenesis and have significantly higher frequency and shorter time to develop HCC than mice carrying either viral protein alone23. The gene discussed is MTOR; the disease is hepatocellular carcinoma.